Clinical Trials for Systemic Sclerosis - 2013 ACR/EULAR Classification Criteria

Find clinical trials for systemic sclerosis - 2013 acr/eular classification criteria. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

Clinical Study of CD7 CAR-T Cells for Relapsed/refractory Autoimmune Diseases

NCT ID: NCT06871644

This clinical trial is studying a new treatment using CD7 CAR-T cells for patients with systemic sclerosis, a type of autoimmune disease that can cause hardening and tightening of the skin and conn...

Not yet recruiting

Phase: NA Type: interventional Locations: Hefei, Anhui, China

KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis

NCT ID: NCT06400303

The KYSA-5 clinical trial is studying a new treatment called Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) therapy for patients with systemic sclerosis, a condition that causes hardening ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Palo Alto, California, United States, Great Neck, New York, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions